Type 3c diabetes Archives

Tag: Type 3c diabetes

Type 3c diabetes develops because of damage to the pancreas, which can happen for a few different reasons. And although it’s different to other types, you can get a wrong diagnosis of type 2 because Type 3c isn’t well known.

Type 3c can happen when the pancreas stops producing enough insulin for the body. And we all need insulin to live. It allows the glucose (or sugar) in our blood to enter our cells and fuel our bodies. If you have Type 3c diabetes your pancreas will also stop producing the enzyme that you need to digest food.

You can only get Type 3c diabetes because of an illness or condition that affects the pancreas, such as:

pancreatitis
pancreatic cancer *
cystic fibrosis
haemochromatosis.

You can also develop Type 3c if you have your pancreas removed.

*note: includes Neuroendocrine Tumours of pancreatic origin

NOTE:

“Type 3 diabetes” is a term that has been proposed to describe the hypothesis that Alzheimer’s disease, which is a major cause of dementia, is triggered by a type of insulin resistance and insulin-like growth factor dysfunction that occurs specifically in the brain. This condition also has been used by some to describe people who have type 2 diabetes and are also diagnosed with Alzheimer’s disease dementia. The classification of type 3 diabetes is highly controversial, and it’s not widely accepted by the medical community as a clinical diagnosis.

The above “type 3 diabetes” medical condition isn’t to be confused with type 3c diabetes mellitus (also called T3cDM, pancreatogenic diabetes, and type 3c diabetes).

Diet and Nutrition, Living with Neuroendocrine Cancer, Survivorship, The NET Effect SeriesAdrenocorticotropic Hormone (ACTH), Afinitor, Blood glucose, Cortisol, Cushing's syndrome, Diabetes, Distal pancreatectomy, Everolimus, Exocrine function (pancreas), Glucagon, Glucagonoma, Glycated Hemoglobin (A1C), HbA1c, Hyperglycemia, Hypoglycemia, Insulin, Insulinoma, Lanreotide, NET syndromes, Octreotide, Pancreas, Pancreatic enzyme replacement therapy (PERT), Pancreatogenic diabetes, Pancreoprivic diabetes, Prediabetes, Somatostatin analogues, Somatostatinoma, Sunitinib (Sutent), Total pancreatectomy, Type 1 diabetes, Type 2 diabetes, Type 3c diabetes, Type 3c diabetes mellitus (T3cDM), Whipple procedure

Diabetes – The NET Effect

By Ronny Allan Jul 24, 2024 3 Comments

Updated January 2026Originally published September 2018. My chest infection is now settled, as too is the excitement and apprehension behind my first ever Ga68 PET - the outcome of that is still a work in progress. Earlier this year, my thyroid 'lesion' on watch and wait was given a 'damping down' with the prescription of a thyroid hormone supplement but I await a re-ignition of that small bush fire downstream. Bubbling behind the scenes and clamouring for attention is the spiking of my blood glucose test results and I was very recently declared 'at risk' for diabetes with a score…